{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:44:19Z","timestamp":1793774659073,"version":"4.6.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T00:00:00Z","timestamp":1424736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11910-015-0539-z","type":"journal-article","created":{"date-parts":[[2015,2,23]],"date-time":"2015-02-23T02:25:27Z","timestamp":1424658327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Inpatient Management of Migraine"],"prefix":"10.1007","volume":"15","author":[{"given":"Michael J.","family":"Marmura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Wrobel","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,24]]},"reference":[{"issue":"9582","key":"539_CR1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0140-6736(07)61064-2","volume":"370","author":"CJ Murray","year":"2007","unstructured":"Murray CJ, Lopez AD, Black R, et al. Global burden of disease 2005: call for collaborators. Lancet. 2007;370(9582):109\u201310.","journal-title":"Lancet"},{"key":"539_CR2","doi-asserted-by":"crossref","unstructured":"Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race and other sociodemographic factors. JAMA. 1992;26764\u201369.","DOI":"10.1001\/jama.1992.03480010072027"},{"issue":"22","key":"539_CR3","first-page":"2941","volume":"265","author":"Anonymous From the Centers for Disease Control","year":"1991","unstructured":"Anonymous From the Centers for Disease Control. Prevalence of chronic migraine headaches\u2014United States, 1980\u20131989. JAMA. 1991;265(22):2941.","journal-title":"JAMA"},{"issue":"15","key":"539_CR4","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1177\/0333102411425960","volume":"31","author":"RP Insinga","year":"2011","unstructured":"Insinga RP, Ng-Mak DS, Hanson ME. Costs associated with outpatient, emergency room and inpatient care for migraine in the USA. Cephalalgia. 2011;31(15):1570\u20135.","journal-title":"Cephalalgia"},{"key":"539_CR5","unstructured":"Lucado J, Paez K, Elixhauser A. Headaches in U.S. Hospitals and Emergency Departments, 2008: Statistical Brief #111. (2006) A relatively unusual look at actual costs of primary headache disorders as they are currently treated, using real-world data."},{"key":"539_CR6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1526-4610.1993.hed3302055.x","volume":"33","author":"AE Lake","year":"1993","unstructured":"Lake AE, Saper JR, Madden SF, Kreeger C. Comprehensive inpatient treatment for intractable migraine: a prospective long-term outcome study. Headache. 1993;33:55\u201362.","journal-title":"Headache"},{"key":"539_CR7","doi-asserted-by":"crossref","unstructured":"Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159813\u2013818.","DOI":"10.1001\/archinte.159.8.813"},{"key":"539_CR8","unstructured":"Vonkorff M, Stewart WF, Simon DS, Lipton RB. Migraine and reduced work performance: a population-based diary study. Neurology. 1998;501741\u20131745."},{"key":"539_CR9","unstructured":"Osterhaus J, Gutterman DL, Pluchetka JR. Healthcare resource and lost labor costs of migraine headache in the United States. Pharmacol Econ. (1992) 267\u201376."},{"issue":"3","key":"539_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1377\/hlthaff.16.3.239","volume":"16","author":"P Fishman","year":"1997","unstructured":"Fishman P, Von KM, Lozano P, Hecht J. Chronic care costs in managed care. Health Aff (Millwood). 1997;16(3):239\u201347.","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"539_CR11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pain.2009.01.013","volume":"142","author":"ME Bigal","year":"2009","unstructured":"Bigal ME, Lipton RB. Excessive opioid use and the development of chronic migraine. Pain. 2009;142(3):179\u201382.","journal-title":"Pain"},{"issue":"1","key":"539_CR12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1468-2982.2008.01697.x","volume":"29","author":"A Ferrari","year":"2009","unstructured":"Ferrari A, Leone S, Tacchi R, et al. The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients. Cephalalgia. 2009;29(1):31\u20137.","journal-title":"Cephalalgia"},{"issue":"6","key":"539_CR13","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1526-4610.2008.01153.x","volume":"48","author":"JR Saper","year":"2008","unstructured":"Saper JR, Lake III AE. Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: limited efficacy, risks, and proposed guidelines. Headache. 2008;48(6):838\u201349. A guideline for management of daily headache, pointing out common pitfalls with opioid use seen in clinical practice.","journal-title":"Headache"},{"issue":"6","key":"539_CR14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1468-2982.2001.00231.x","volume":"21","author":"GG Tribl","year":"2001","unstructured":"Tribl GG, Schnider P, Wober C, et al. Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache? Cephalalgia. 2001;21(6):691\u20136.","journal-title":"Cephalalgia"},{"issue":"7","key":"539_CR15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1526-4610.1999.3907477.x","volume":"39","author":"F Radat","year":"1999","unstructured":"Radat F, Sakh D, Lutz G, et al. Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs. Headache. 1999;39(7):477\u201380.","journal-title":"Headache"},{"issue":"8","key":"539_CR16","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1212\/WNL.0b013e3182825055","volume":"80","author":"J Schoenen","year":"2013","unstructured":"Schoenen J, Vandersmissen B, Jeangette S, et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013;80(8):697\u2013704.","journal-title":"Neurology"},{"issue":"12","key":"539_CR17","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1468-2982.2005.00980.x","volume":"25","author":"P Zeeberg","year":"2005","unstructured":"Zeeberg P, Olesen J, Jensen R. Efficacy of multidisciplinary treatment in a tertiary referral headache centre. Cephalalgia. 2005;25(12):1159\u201367.","journal-title":"Cephalalgia"},{"issue":"5","key":"539_CR18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10194-011-0364-y","volume":"12","author":"C Gaul","year":"2011","unstructured":"Gaul C, Visscher CM, Bhola R, et al. Team players against headache: multidisciplinary treatment of primary headaches and medication overuse headache. J Headache Pain. 2011;12(5):511\u20139. An excellent overview of comprehensive headache management.","journal-title":"J Headache Pain"},{"issue":"2","key":"539_CR19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/head.12273","volume":"54","author":"P Rizzoli","year":"2014","unstructured":"Rizzoli P. Preventive pharmacotherapy in migraine. Headache. 2014;54(2):364\u20139.","journal-title":"Headache"},{"issue":"9","key":"539_CR20","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/0333102411409075","volume":"31","author":"HC Diener","year":"2011","unstructured":"Diener HC, Gaul C, Jensen R, et al. Integrated headache care. Cephalalgia. 2011;31(9):1039\u201347.","journal-title":"Cephalalgia"},{"key":"539_CR21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1526-4610.2004.04093.x","volume":"44","author":"FG Freitag","year":"2004","unstructured":"Freitag FG, Lake A, Lipton RB, et al. Inpatient treatment of headache: an evidence-based assessment. United States Headache Guidelines Consortium. Headache. 2004;44:342\u201360. The most complete evidence and experience-based review of inpatient headache management to date.","journal-title":"Headache"},{"issue":"20","key":"539_CR22","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.9734\/BJMMR\/2014\/9111","volume":"4","author":"CO Dougherty","year":"2014","unstructured":"Dougherty CO, Marmura MJ, Ergonul Z, Charleston LC, Szperka CL. Emergency and inpatient treatment of migraine: an American Headache Society survey. Brit J Med Med Res. 2014;4(20):3800\u201313. A recent expert opinion paper on the topic of emergency and inpatient management.","journal-title":"Brit J Med Med Res"},{"key":"539_CR23","volume-title":"Handbook of headache management","author":"JR Saper","year":"1993","unstructured":"Saper JR, Silberstein SD, Gordon CD, et al. Handbook of headache management. In: Saper JR, Silberstein SD, Gordon CD, Hamel RL, editors. Handbook of headache management. Baltimore: Williams & Wilkins; 1993."},{"issue":"7","key":"539_CR24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3949\/ccjm.64.7.373","volume":"64","author":"GD Solomon","year":"1997","unstructured":"Solomon GD, Cady RK, Klapper JA, Ryan Jr RE. Standards of care for treating headache in primary care practice. National Headache Foundation. Cleve Clin J Med. 1997;64(7):373\u201383.","journal-title":"Cleve Clin J Med"},{"key":"539_CR25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1526-4610.1995.hed3506349.x","volume":"35","author":"SS Villarreal","year":"1995","unstructured":"Villarreal SS. A comparative study of selected patient variables as risk factors in hospitalization for chronic headache. Headache. 1995;35:349\u201354.","journal-title":"Headache"},{"issue":"4","key":"539_CR26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1526-4610.2009.01364.x","volume":"49","author":"AE Lake III","year":"2009","unstructured":"Lake III AE, Saper JR, Hamel RL. Comprehensive inpatient treatment of refractory chronic daily headache. Headache. 2009;49(4):555\u201362. A recent overview of chronic daily headache management with insight from the medical and psychological perspective.","journal-title":"Headache"},{"key":"539_CR27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1526-4610.1986.hed2604189.x","volume":"26","author":"S Diamond","year":"1986","unstructured":"Diamond S, Freitag FG, Maliszewski M. Inpatient treatment of headache: long-term results. Headache. 1986;26:189\u201397.","journal-title":"Headache"},{"issue":"Suppl 11","key":"539_CR28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0333102491011S1165","volume":"11","author":"SL Linder","year":"1991","unstructured":"Linder SL. Treatment of acute childhood migraine headaches. Cephalalgia. 1991;11 Suppl 11:120\u20131.","journal-title":"Cephalalgia"},{"key":"539_CR29","doi-asserted-by":"crossref","unstructured":"Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology. 1986;36995\u2013997.","DOI":"10.1212\/WNL.36.7.995"},{"key":"539_CR30","doi-asserted-by":"crossref","unstructured":"Silberstein SD, Silberstein JR. Chronic daily headache: prognosis following inpatient treatment with repetitive IV DHE. Headache. 1992;32439\u2013445.","DOI":"10.1111\/j.1526-4610.1992.hed3209439.x"},{"key":"539_CR31","doi-asserted-by":"crossref","unstructured":"Pringsheim T, Howse D. Inpatient treatment of chronic daily headache using dihydroergotamine: a long-term follow-up study. Can J Neurol Sci. 1998;25146\u2013150.","DOI":"10.1017\/S031716710003376X"},{"issue":"20","key":"539_CR32","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0b013e3182377dbb","volume":"77","author":"AJ Nagy","year":"2011","unstructured":"Nagy AJ, Gandhi S, Bhola R, Goadsby PJ. Intravenous dihydroergotamine for inpatient management of refractory primary headaches. Neurology. 2011;77(20):1827\u201332. One of a few recent large inpatient studies of DHE.","journal-title":"Neurology"},{"key":"539_CR33","doi-asserted-by":"crossref","unstructured":"Jauslin P, Goadsby PJ, Lance JW. The hospital management of severe migrainous headache. Headache. 1991;31658\u2013660.","DOI":"10.1111\/j.1526-4610.1991.hed3110658.x"},{"issue":"5","key":"539_CR34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1468-2982.2006.01073.x","volume":"26","author":"G Relja","year":"2006","unstructured":"Relja G, Granato A, Bratina A, Antonello RM, Zorzon M. Outcome of medication overuse headache after abrupt in-patient withdrawal. Cephalalgia. 2006;26(5):589\u201395.","journal-title":"Cephalalgia"},{"key":"539_CR35","unstructured":"Diener HC. The efficacy and safety of acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized multicenter, parallel group study. The ASASUMAMIG Study Group. Eur Neurol. (1999)."},{"issue":"4","key":"539_CR36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1526-4610.2005.05065.x","volume":"45","author":"RB Lipton","year":"2005","unstructured":"Lipton RB, Goldstein J, Baggish JS, et al. Aspirin is efficacious for the treatment of acute migraine. Headache. 2005;45(4):283\u201392.","journal-title":"Headache"},{"issue":"12","key":"539_CR37","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1212\/WNL.0b013e3181f39a11","volume":"75","author":"MW Weatherall","year":"2010","unstructured":"Weatherall MW, Telzerow AJ, Cittadini E, Kaube H, Goadsby PJ. Intravenous aspirin (lysine acetylsalicylate) in the inpatient management of headache. Neurology. 2010;75(12):1098\u2013103. A novel inpatient approach to daily headache in the hospital setting.","journal-title":"Neurology"},{"issue":"6","key":"539_CR38","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1526-4610.2002.02127.x","volume":"42","author":"TH Schwartz","year":"2002","unstructured":"Schwartz TH, Karpitskiy VV, Sohn RS. Intravenous valproate sodium in the treatment of daily headache. Headache. 2002;42(6):519\u201322.","journal-title":"Headache"},{"issue":"1","key":"539_CR39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1526-4610.2004.04010.x","volume":"44","author":"MJ Stillman","year":"2004","unstructured":"Stillman MJ, Zajac D, Rybicki LA. Treatment of primary headache disorders with intravenous valproate: initial outpatient experience. Headache. 2004;44(1):65\u20139.","journal-title":"Headache"},{"key":"539_CR40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1468-2982.1999.1901001.x","volume":"19","author":"NT Mathew","year":"1999","unstructured":"Mathew NT, Kailasam J, Meadors L, Gentry P, Chernyshev O. Intravenous valproate sodium (Depaconr) aborts migraine rapidly: a preliminary report. Cephalalgia. 1999;19:373. Abstract.","journal-title":"Cephalalgia"},{"issue":"10","key":"539_CR41","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1046\/j.1526-4610.2001.01191.x","volume":"41","author":"KR Edwards","year":"2001","unstructured":"Edwards KR, Norton J, Behnke M. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache. 2001;41(10):976\u201380.","journal-title":"Headache"},{"issue":"10","key":"539_CR42","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1046\/j.1468-2982.2003.00623.x","volume":"23","author":"DR Williams","year":"2003","unstructured":"Williams DR, Stark RJ. Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia. 2003;23(10):963\u201371.","journal-title":"Cephalalgia"},{"issue":"2","key":"539_CR43","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1526-4610.2008.01281.x","volume":"49","author":"N Rosen","year":"2009","unstructured":"Rosen N, Marmura M, Abbas M, Silberstein S. Intravenous lidocaine in the treatment of refractory headache: a retrospective case series. Headache. 2009;49(2):286\u201391. A large review of lidocaine for chronic migraine and other headaches in the inpatient setting, with or without adjunctive medication.","journal-title":"Headache"},{"issue":"10","key":"539_CR44","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1526-4610.2008.01234.x","volume":"48","author":"MJ Marmura","year":"2008","unstructured":"Marmura MJ, Passero Jr FC, Young WB. Mexiletine for refractory chronic daily headache: a report of nine cases. Headache. 2008;48(10):1506\u201310.","journal-title":"Headache"},{"key":"539_CR45","first-page":"1399","volume":"26","author":"R Gil-Gouveia","year":"2006","unstructured":"Gil-Gouveia R, Goadsby PJ. Neuropsychiatric side effects of lidocaine: examples from the treatment of headache and a review. Cephalalgia. 2006;26:1399. Abstract.","journal-title":"Cephalalgia"},{"issue":"5","key":"539_CR46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1468-2982.2002.00364.x","volume":"22","author":"ME Bigal","year":"2002","unstructured":"Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia. 2002;22(5):345\u201353.","journal-title":"Cephalalgia"},{"issue":"2","key":"539_CR47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1526-4610.2001.111006171.x","volume":"41","author":"S Demirkaya","year":"2001","unstructured":"Demirkaya S, Vural O, DORA B, Topcuoglu MA. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache. 2001;41(2):171\u20137.","journal-title":"Headache"},{"issue":"5","key":"539_CR48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1017\/S1481803500009593","volume":"6","author":"LR Frank","year":"2004","unstructured":"Frank LR, Olson CM, Shuler KB, Gharib SF. Intravenous magnesium for acute benign headache in the emergency department: a randomized double-blind placebo-controlled trial. CJEM. 2004;6(5):327\u201332.","journal-title":"CJEM"},{"issue":"1","key":"539_CR49","first-page":"2","volume":"21","author":"H Choi","year":"2014","unstructured":"Choi H, Parmar N. The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized controlled trials. Eur J Emerg Med. 2014;21(1):2\u20139.","journal-title":"Eur J Emerg Med"},{"issue":"3","key":"539_CR50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1468-2982.2004.00840.x","volume":"25","author":"Y Cete","year":"2005","unstructured":"Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department. Cephalalgia. 2005;25(3):199\u2013204.","journal-title":"Cephalalgia"},{"issue":"3","key":"539_CR51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0736-4679(99)00220-6","volume":"18","author":"S Ginder","year":"2000","unstructured":"Ginder S, Oatman B, Pollack M. A prospective study of i.v. magnesium and i.v. prochlorperazine in the treatment of headaches. J Emerg Med. 2000;18(3):311\u20135.","journal-title":"J Emerg Med"},{"issue":"23","key":"539_CR52","doi-asserted-by":"crossref","first-page":"865","DOI":"10.5694\/j.1326-5377.1976.tb141126.x","volume":"1","author":"BW Somerville","year":"1976","unstructured":"Somerville BW. Treatment of migraine attacks with an analgesic combination (Mersyndol). Med J Aust. 1976;1(23):865\u20136.","journal-title":"Med J Aust"},{"issue":"1","key":"539_CR53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11916-005-0077-5","volume":"9","author":"SZ Swidan","year":"2005","unstructured":"Swidan SZ, Lake III AE, Saper JR. Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache. Curr Pain Headache Rep. 2005;9(1):65\u201370.","journal-title":"Curr Pain Headache Rep"},{"key":"539_CR54","doi-asserted-by":"crossref","unstructured":"Orr sl, Aube M, Becker WJ, et al. Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings. Cephalalgia (2014).","DOI":"10.1177\/0333102414535997"},{"issue":"1","key":"539_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.annemergmed.2009.11.020","volume":"56","author":"MA Kostic","year":"2010","unstructured":"Kostic MA, Gutierrez FJ, Rieg TS, Moore TS, Gendron RT. A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department. Ann Emerg Med. 2010;56(1):1\u20136.","journal-title":"Ann Emerg Med"},{"key":"539_CR56","doi-asserted-by":"crossref","unstructured":"Jones EB, Gonzales ER, Boggs JG, Grillo JA, Elswick JR RK. Safety and efficacy of rectal prochlorperazine for the treatment of migraine in the emergency department. Ann Emerg Med. 1994;24237\u2013241.","DOI":"10.1016\/S0196-0644(94)70135-0"},{"issue":"8","key":"539_CR57","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/jama.1989.03420080094038","volume":"261","author":"J Jones","year":"1989","unstructured":"Jones J, Sklar D, Dougherty J, White W. Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. JAMA. 1989;261(8):1174\u20136.","journal-title":"JAMA"},{"key":"539_CR58","doi-asserted-by":"crossref","unstructured":"Wang SJ, Silberstein SD, Young WB. Droperidol treatment of status migrainosus and refractory migraine. Headache. 1997;37377\u2013382.","DOI":"10.1046\/j.1526-4610.1997.3706377.x"},{"issue":"2","key":"539_CR59","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/01.WNL.0000042477.63516.B2","volume":"60","author":"SD Silberstein","year":"2003","unstructured":"Silberstein SD, Young WB, Mendizabal JE, Rothrock JF, Alam AS. Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial. Neurology. 2003;60(2):315\u201321.","journal-title":"Neurology"},{"issue":"2","key":"539_CR60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0736-4679(02)00502-4","volume":"23","author":"ME Bigal","year":"2002","unstructured":"Bigal ME, Bordini CA, Speciali JG. Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial. J Emerg Med. 2002;23(2):141\u20138.","journal-title":"J Emerg Med"},{"key":"539_CR61","doi-asserted-by":"crossref","unstructured":"Lane PL, Mclellan BA, Boggoley CJ. Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Ann Emerg Med. 1989;18360\u2013365.","DOI":"10.1016\/S0196-0644(89)80570-0"},{"issue":"5","key":"539_CR62","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1526-4610.2006.00438.x","volume":"46","author":"J Honkaniemi","year":"2006","unstructured":"Honkaniemi J, Liimatainen S, Rainesalo S, Sulavuori S. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study. Headache. 2006;46(5):781\u20137.","journal-title":"Headache"},{"key":"539_CR63","doi-asserted-by":"crossref","unstructured":"Klapper JA, Stanton JS. Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches. Headache. 1991;31523\u2013524.","DOI":"10.1111\/j.1526-4610.1991.hed3108523.x"},{"key":"539_CR64","doi-asserted-by":"crossref","unstructured":"Tfelt-Hansen P, Olesen J, Aebelholt-Krabbe A, Melgaard B, Veilis B. A double blind study of metoclopramide in the treatment of migraine attacks. J Neurol Neurosurg Psychiatry. 1980;43369\u2013371.","DOI":"10.1136\/jnnp.43.4.369"},{"issue":"3","key":"539_CR65","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1526-4610.2000.00032.x","volume":"40","author":"JC Krusz","year":"2000","unstructured":"Krusz JC, Scott V, Belanger J. Intravenous propofol: unique effectiveness in treating intractable migraine. Headache. 2000;40(3):224\u201330.","journal-title":"Headache"},{"issue":"6","key":"539_CR66","doi-asserted-by":"crossref","first-page":"646","DOI":"10.5811\/westjem.2013.7.18081","volume":"14","author":"J Mosier","year":"2013","unstructured":"Mosier J, Roper G, Hays D, Guisto J. Sedative dosing of propofol for treatment of migraine headache in the emergency department: a case series. West J Emerg Med. 2013;14(6):646\u20139.","journal-title":"West J Emerg Med"},{"issue":"1","key":"539_CR67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1865-1380-5-19","volume":"5","author":"H Soleimanpour","year":"2012","unstructured":"Soleimanpour H, Taheraghdam A, Ghafouri RR, et al. Improvement of refractory migraine headache by propofol: case series. Int J Emerg Med. 2012;5(1):19.","journal-title":"Int J Emerg Med"},{"issue":"7","key":"539_CR68","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1526-4610.2002.02151.x","volume":"42","author":"PM Mendes","year":"2002","unstructured":"Mendes PM, Silberstein SD, Young WB, Rozen TD, Paolone MF. Intravenous propofol in the treatment of refractory headache. Headache: J Head Face Pain. 2002;42(7):638\u201341. One of the largest studies looking at propofol for the treatment of intractable pain.","journal-title":"Headache: J Head Face Pain"},{"issue":"1 Pt 1","key":"539_CR69","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1542\/peds.90.1.5","volume":"90","author":"DS Nelson","year":"1992","unstructured":"Nelson DS, Walsh K, Fleisher GR. Spectrum and frequency of pediatric illness presenting to a general community hospital emergency department. Pediatrics. 1992;90(1 Pt 1):5\u201310.","journal-title":"Pediatrics"},{"issue":"1","key":"539_CR70","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/088307388700200104","volume":"2","author":"RS Kandt","year":"1987","unstructured":"Kandt RS, Levine RM. Headache and acute illness in children. J Child Neurol. 1987;2(1):22\u20137.","journal-title":"J Child Neurol"},{"issue":"3","key":"539_CR71","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1046\/j.1526-4610.2000.00029.x","volume":"40","author":"DW Lewis","year":"2000","unstructured":"Lewis DW, Qureshi F. Acute headache in children and adolescents presenting to the emergency department. Headache. 2000;40(3):200\u20133.","journal-title":"Headache"},{"issue":"1","key":"539_CR72","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1526-4610.2008.01293.x","volume":"49","author":"MA Kabbouche","year":"2009","unstructured":"Kabbouche MA, Powers SW, Segers A, et al. Inpatient treatment of status migraine with dihydroergotamine in children and adolescents. Headache. 2009;49(1):106\u20139. One of only a few pediatric studies focusing on the treatment of chronic migraine.","journal-title":"Headache"},{"issue":"4","key":"539_CR73","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1542\/peds.107.4.e62","volume":"107","author":"MA Kabbouche","year":"2001","unstructured":"Kabbouche MA, Vockell AL, Lecates SL, Powers SW, Hershey AD. Tolerability and effectiveness of prochlorperazine for intractable migraine in children. Pediatrics. 2001;107(4):E62.","journal-title":"Pediatrics"},{"issue":"10","key":"539_CR74","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/0009922813492879","volume":"52","author":"M Raina","year":"2013","unstructured":"Raina M, Chelimsky G, Chelimsky T. Intravenous dihydroergotamine therapy for pediatric abdominal migraines. Clin Pediatr (Phila). 2013;52(10):918\u201321.","journal-title":"Clin Pediatr (Phila)"},{"key":"539_CR75","first-page":"299","volume":"30","author":"A Lake","year":"1990","unstructured":"Lake A, Saper J, Madden S, Kreeger C. Inpatient treatment for chronic daily headache: a prospective long-term outcome. Headache. 1990;30:299\u2013300. Abstract.","journal-title":"Headache"},{"issue":"1","key":"539_CR76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000096383","volume":"40","author":"G Lanzi","year":"2007","unstructured":"Lanzi G, D\u2019Arrigo S, Termine C, et al. The effectiveness of hospitalization in the treatment of paediatric idiopathic headache patients. Psychopathology. 2007;40(1):1\u20137.","journal-title":"Psychopathology"},{"issue":"2","key":"539_CR77","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/AJP.0b013e318185c1c9","volume":"25","author":"T Hechler","year":"2009","unstructured":"Hechler T, Dobe M, Kosfelder J, et al. Effectiveness of a 3-week multimodal inpatient pain treatment for adolescents suffering from chronic pain: statistical and clinical significance. Clin J Pain. 2009;25(2):156\u201366.","journal-title":"Clin J Pain"},{"issue":"6","key":"539_CR78","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaneurol.2014.133","volume":"71","author":"M Wall","year":"2014","unstructured":"Wall M, Kupersmith MJ, Kieburtz KD, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol. 2014;71(6):693\u2013701.","journal-title":"JAMA Neurol"},{"key":"539_CR79","doi-asserted-by":"crossref","unstructured":"Silberstein SD. Practice parameter\u2013evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology for the United States Headache Consortium. Neurology. 2000;55754\u2013762.","DOI":"10.1212\/WNL.55.6.754"},{"key":"539_CR80","doi-asserted-by":"crossref","unstructured":"Buse DC, Manack AN, Fanning KM, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;521456\u20131470.","DOI":"10.1111\/j.1526-4610.2012.02223.x"},{"issue":"1","key":"539_CR81","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1526-4610.2009.01557.x","volume":"50","author":"GE Tietjen","year":"2010","unstructured":"Tietjen GE, Brandes JL, Peterlin BL, et al. Childhood maltreatment and migraine (part II). Emotional abuse as a risk factor for headache chronification. Headache. 2010;50(1):32\u201341.","journal-title":"Headache"},{"issue":"1","key":"539_CR82","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1526-4610.2009.01459.x","volume":"50","author":"BL Peterlin","year":"2010","unstructured":"Peterlin BL, Rosso AL, Rapoport AM, Scher AI. Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache. 2010;50(1):52\u201362.","journal-title":"Headache"},{"issue":"13","key":"539_CR83","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1212\/WNL.0b013e318212ab1e","volume":"76","author":"DS Bond","year":"2011","unstructured":"Bond DS, Vithiananthan S, Nash JM, Thomas JG, Wing RR. Improvement of migraine headaches in severely obese patients after bariatric surgery. Neurology. 2011;76(13):1135\u20138.","journal-title":"Neurology"},{"key":"539_CR84","unstructured":"Lipton RB, Stewart WF, Sawyer J. Stratified care is a more effective migraine treatment strategy than stepped care: results of a randomized clinical trial. Neurology. (2000) 54A14."}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-015-0539-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-015-0539-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-015-0539-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T12:11:13Z","timestamp":1651320673000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-015-0539-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,24]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["539"],"URL":"https:\/\/doi.org\/10.1007\/s11910-015-0539-z","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,24]]},"article-number":"13"}}